| scholarly article | Q13442814 |
| P2093 | author name string | E Balish | |
| M T Cantorna | |||
| P2860 | cites work | Growth and Invasiveness of Candida albicans in the Germ-Free and Conventional Mouse After Oral Challenge | Q33697118 |
| Effects of cyclophosphamide on murine candidiasis | Q33899016 | ||
| Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency | Q34055177 | ||
| Growth and virulence of Candida albicans after oral inoculation in the chick with a monoflora of either Escherichia coli or Streptococcus faecalis | Q35179530 | ||
| Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans | Q35539715 | ||
| Mammary gland contamination as a means of establishing long-term gastrointestinal colonization of infant mice with Candida albicans | Q36338220 | ||
| Immune responses to Candida albicans in genetically distinct mice. | Q36339441 | ||
| Increase of mouse resistance to Candida albicans infection by thymosin alpha 1 | Q36440983 | ||
| Persistence and spread of Candida albicans after intragastric inoculation of infant mice | Q36443363 | ||
| Colonization of congenitally athymic, gnotobiotic mice by Candida albicans | Q36678376 | ||
| Immunity to Candida albicans | Q37065833 | ||
| Esophageal candidiasis. Managing an increasingly prevalent infection | Q39511843 | ||
| Genetically determined murine models of immunodeficiency | Q39657786 | ||
| Chronic Mucocutaneous Candidiasis: Model-Building in Cellular Immunity | Q39998391 | ||
| Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice | Q40153154 | ||
| Oral candidiasis: pathogenesis and host defense | Q40173636 | ||
| Role of activated macrophages in resistance to systemic candidosis | Q41373593 | ||
| Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality | Q43662909 | ||
| Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome | Q44170824 | ||
| The cellular immune defect in chronic mucocutaneous candidiasis | Q44245250 | ||
| Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis | Q44668019 | ||
| Characterization and significance of abnormal leukocyte granules in the beige mouse: a possible homologue for Chediak-Higashi Aleutian trait. | Q54294657 | ||
| Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice. | Q54488274 | ||
| Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. | Q54534008 | ||
| Resistance of germfree mice to systemic candidosis. | Q54538310 | ||
| The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function | Q54565583 | ||
| Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice | Q67480065 | ||
| X-linked immune deficiency (xid) of CBA/N mice | Q68798401 | ||
| Studies on beige-nude mice with low natural killer cell activity. 1. Introduction of the bg gene into nude mice and the characteristics of beige-nude mice | Q68969173 | ||
| The Chediak-Higashi Syndrome: Studies of Host Defenses | Q69156904 | ||
| A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis | Q69352287 | ||
| Reduced CD4 + T cells and severe oral candidiasis in absence of HIV infection | Q69368248 | ||
| Strain-dependent differences in susceptibility of mice to experimental candidosis | Q69644553 | ||
| Effects of smoking on the prevalence and intraoral distribution of Candida albicans | Q70485459 | ||
| The effect of microbial flora, diet, and age on the tumoricidal activity of natural killer cells | Q70964107 | ||
| Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model | Q71131291 | ||
| Predominance of B-lymphocyte function after cultured thymus fragment therapy in severe combined immunodeficiency disease | Q72080888 | ||
| The prevalence and intra-oral distribution of Candida albicans in man | Q72147639 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | candidiasis | Q273510 |
| congenital disorder | Q727096 | ||
| P304 | page(s) | 1093-1100 | |
| P577 | publication date | 1990-04-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Mucosal and systemic candidiasis in congenitally immunodeficient mice | |
| P478 | volume | 58 |
| Q37315206 | A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia |
| Q35629652 | Animal models of mucosal Candida infection |
| Q58855438 | Antigen-specific cytolysis of infected cells in murine candidiasis |
| Q90308249 | Applying the Host-Microbe Damage Response Framework to Candida Pathogenesis: Current and Prospective Strategies to Reduce Damage |
| Q24673175 | Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice |
| Q34492756 | CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1. |
| Q36080619 | Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework |
| Q58855442 | Candida albicans-specific Ly-2+ lymphocytes with cytolytic activity |
| Q24550731 | Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans |
| Q33596378 | Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. |
| Q52577946 | Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. |
| Q33605733 | Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans |
| Q42216368 | Differential role of NK cells against Candida albicans infection in immunocompetent or immunocompromised mice |
| Q39515324 | Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis |
| Q37358668 | Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract. |
| Q33600274 | Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunodeficiency. |
| Q35775332 | Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis |
| Q34399977 | Effects of salivary protein flow and indigenous microorganisms on initial colonization of Candida albicans in an in vivo model |
| Q67851024 | Elimination of Candida albicans from kidneys of mice during short-term systemic infections |
| Q33975696 | Experimental oral candidiasis in animal models |
| Q35410834 | Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis |
| Q30452828 | Expression of surface hydrophobic proteins by Candida albicans in vivo. |
| Q33620818 | Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection |
| Q36965230 | Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome |
| Q36971624 | Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice |
| Q35659934 | Hosting infection: experimental models to assay Candida virulence |
| Q34143094 | Immunity to Candida |
| Q35920633 | Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. |
| Q34397458 | Immunopathogenesis of recurrent vulvovaginal candidiasis. |
| Q36366415 | Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans |
| Q34204874 | Inflammation and gastrointestinal Candida colonization |
| Q33967498 | Intestinal lesions associated with disseminated candidiasis in an experimental animal model. |
| Q34002426 | Local production of chemokines during experimental vaginal candidiasis |
| Q36973976 | Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. |
| Q36574240 | Macrophages in resistance to candidiasis |
| Q34524422 | Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model |
| Q36900988 | Mouse model of oropharyngeal candidiasis |
| Q38137645 | Murine models of Candida gastrointestinal colonization and dissemination |
| Q36231505 | Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis |
| Q35125491 | New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents. |
| Q35397050 | Nitric oxide production does not directly increase macrophage candidacidal activity |
| Q77780883 | Nitric oxide-enhanced resistance to oral candidiasis |
| Q35567366 | Oral carriage of Candida albicans in murine AIDS. |
| Q35105915 | Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice |
| Q36969872 | Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis |
| Q34117577 | Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis |
| Q36670422 | Production and function of cytokines in natural and acquired immunity to Candida albicans infection |
| Q40268374 | Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line |
| Q77164050 | Protective immunity in experimental Candida vaginitis |
| Q35553521 | Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats |
| Q68240531 | Protein-calorie malnutrition impairs host defense against Candida albicans |
| Q35795061 | Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice |
| Q35108191 | Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis |
| Q40151121 | Role of CD4+ lymphocytes in resistance to mucosal candidiasis |
| Q58855415 | Specific and non-specific immunity to Candida albicans a lesson from genetically modified animals |
| Q33716171 | Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin |
| Q34009240 | T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis |
| Q40928708 | T helper cell dichotomy to Candida albicans: implications for pathology, therapy, and vaccine design. |
| Q40156361 | Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. |
| Q44967960 | The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects |
Search more.